Levosimendan and Myocardial Protection

Myocardial Protection Clinical Trial

Official title:
Levosimendan Pre-Treatment in Patients Undergoing Coronary Artery Bypass Graft Surgery: a Double-Blind, Single Center, Prospective, Randomized, Placebo-Controlled Trial

Status Completed

Clinical Trial Summary

The aim of this study is to investigate whether pharmacological pre-treatment with levosimendan reduces intensive care unit (ICU) length of stay in patients undergoing elective myocardial revascularization under cardiopulmonary bypass.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Myocardial Protection

Clinical Trial Details

NCT number	NCT00610350
Study type	Interventional
Source	University of Roma La Sapienza
Contact
Status	Completed
Phase	Phase 4
Start date	January 2005
Completion date	February 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00546390` - Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study	N/A
Completed	`NCT01941420` - Comparison of Blood and Crystalloid Cardioplegia	N/A
Completed	`NCT01941459` - Comparison of Blood Cardioplegia and Custodiol	N/A
Completed	`NCT03859115` - Effects of TENS on Myocardial Protection in Patients Undergoing AVR	N/A
Completed	`NCT04231903` - Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Completed	`NCT06287372` - Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
Not yet recruiting	`NCT03595111` - Myocardial Biopsy in Congenital Cardiac Surgery	N/A